Hemolysis is the destruction of red blood cells (RBCs). Typically, RBCs can live for up to 120 days before the body naturally destroys them. However, certain conditions and medications may cause them ...

The phase 3 PEGASUS trial found that patients with paroxysmal nocturnal hemoglobinuria (PNH) may still experience anemia following recommended therapies, underscoring the need for further research. In ...

The figure focuses on complement activation by means of the alternative pathway because it is the one responsible for hemolysis in PNH. The lightning bolt symbolizes the spontaneous hydrolytic ...

BERLIN, Germany—Evidence of hemolysis was detected in the vast majority of patients undergoing pulsed-field ablation (PFA) for atrial fibrillation (AF) in a prospective study conducted at four ...

A research team from The Netherlands investigated the consequences of hemolysis for intestinal blood flow and its possible association with intestinal injury. They found that intestinal injury was ...

"Our previous work showed that SARS-CoV-2 spike proteins lead to complement dysregulation by binding heparan sulfate and disrupting complement factor H…This doesn’t happen on red cells because red ...

red blood cells The FDA has granted Priority Review for the Biologics License Application (BLA) for sutimlimab for the treatment of hemolysis in adult patients with cold agglutinin disease, a rare ...

Hemolysis of serum and plasma samples is a common problem in veterinary diagnostic laboratories. We measured the effects of hemolysis on nine plasma analytes in 10 clinically normal common green ...

On 14 April 2020, the Belgian Federal Agency for Medicines and Health Products (AFMPS), published a news flash warning physicians of the risk of hemolysis associated with the use of hydroxychloroquine ...

The earliest description of an incompatible hemolytic transfusion reaction dates to the experimental start of transfusion therapy in the mid-17th century. While treating a nobleman who had episodes of ...